What Researchers Did
Researchers reported on a single patient who developed severe eye complications after a common eye surgery and was then treated with hyperbaric oxygen therapy.
What They Found
A male patient developed scleral necrosis 20 days after pterygium removal surgery, following the application of 0.4 mg/mL topical mitomycin C eye drops for three weeks. After other treatments failed, the patient received 24 sessions of hyperbaric oxygen therapy. This treatment led to the revascularization of the sclera, which returned to near normal thickness.
What This Means for Canadian Patients
For Canadian patients undergoing pterygium surgery who develop scleral necrosis due to mitomycin C, this case suggests hyperbaric oxygen therapy could be a potential treatment option. It offers hope for recovery from a complication that can severely affect vision and eye health.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
As a case report, this study only describes the experience of one patient, so its findings cannot be broadly applied to others without further research.